Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil ± lovastatin
- 15 June 1993
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (16) , 1485-1488
- https://doi.org/10.1016/0002-9149(93)90624-l
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Factors influencing the development of hypercholesterolemia after cardiac transplantationThe American Journal of Cardiology, 1992
- Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendationsJournal of the American College of Cardiology, 1992
- Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heartInternational Journal of Cardiology, 1991
- Lovastatin therapy for hypercholesterolemia in cardiac transplant recipientsThe American Journal of Cardiology, 1989
- Frequency of hypercholesterolemia after cardiac transplantationThe American Journal of Cardiology, 1988
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- GemfibrozilDrugs, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation, 1987
- Weight Change Since Age 18 Years in 30- to 55-Year-Old Whites and BlacksPublished by American Medical Association (AMA) ,1983